Skip to content

Drug interactions

Rifabutin + Sorafenib

Severity: Moderate

Rifabutin and Sorafenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifabutin is a CYP3A4 inducer and may lower sorafenib exposure, which could reduce its antitumor efficacy. The inducing effect of rifabutin is weaker than that of rifampin, and the clinical impact on sorafenib is likely modest.

What this interaction means in plain words

Rifabutin and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rifabutin belongs to Anti Bacterial; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Rifabutin induces CYP3A4, increasing the metabolism of sorafenib.

What to do

Consider an alternative to rifabutin if feasible. Monitor tumor response and consider whether a sorafenib dose increase is needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rifabutin and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rifabutin with Sorafenib?

MediHelp rates the interaction as moderate. Rifabutin and Sorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rifabutin is a CYP3A4 inducer and may lower sorafenib exposure, which could reduce its antitumor efficacy. The inducing effect of rifabutin is weaker than that of rifampin, and the clinical impact on sorafenib is likely modest.

How serious is the interaction between Rifabutin and Sorafenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an alternative to rifabutin if feasible. Monitor tumor response and consider whether a sorafenib dose increase is needed.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in